Hussman Strategic Advisors Exits Position in Biotech Firm TG Therapeutics
Investment firm Hussman Strategic Advisors has liquidated its entire stake in TG Therapeutics, a move that comes as the biotech's stock lags behind broader market gains despite reporting strong revenue growth for its flagship product.